Loading clinical trials...
Loading clinical trials...
Biological Study of Feasibility Concerning the Research for Mutation of the Gene of EGFR and for K-Ras in Circulating Tumoral Cells(CTCs) of the Patients Carriers of Metastatic Non Small Cells Bronchial Carcinomas
Conditions
Interventions
CTC
Locations
1
France
Centre Georges François Leclerc
Dijon, France
Start Date
March 9, 2011
Primary Completion Date
March 9, 2011
Completion Date
June 1, 2019
Last Updated
January 27, 2020
NCT07250477
NCT06517953
NCT04563338
NCT04163432
NCT04504071
NCT03469960
Lead Sponsor
Centre Georges Francois Leclerc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions